(Q43725563)

English

The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Peer Carsten Tfelt-Hansen

2

object named as

P Tfelt-Hansen

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

4

object named as

M D Ferrari

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Hans-Christoph Diener

1

object named as

H C Diener

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

F de Beukelaar

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

C Dahlöf

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

N Mathew

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Study Group

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

672-679

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

The antimigraine agent alniditan selectively constricts porcine carotid arteriovenous anastomoses via 5-HT1B/1D receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Methodology of clinical trials of sumatriptan in migraine and cluster headache

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Verbal scales in the acute treatment of migraine: semantic categories and clinical relevance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1046%2FJ.0333-1024.2001.00222.X

21 January 2018

Identifiers

10.1046/J.0333-1024.2001.00222.X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43725563&oldid=2102860611"